Chris McClain

Chris McClain, MBA

Senior Vice President, Sales and Business Development


As Senior Vice President, Sales, Marketing and Business Development, Chris’ team engages with cell and gene therapy companies developing innovative, life-saving therapies that can leverage the cell sourcing, cell therapy supply chain, research support and outcomes tracking capabilities of NMDP.

Before joining NMDP BioTherapies, Chris was co-founder of Nora Therapeutics, Inc., a venture-backed biopharmaceutical company developing novel therapies in areas of significant unmet medical need in reproductive health. While at Nora Therapeutics, Chris and his team raised more than $50 million in venture capital to fund pre-clinical and clinical development of Nora’s lead asset and build out a world-class executive team.

Prior to founding Nora Therapeutics, Chris held a variety of management consulting and operational roles in the technology sector.

He has served as an advisory member of the University of Minnesota Office for Technology Commercialization Venture Center, a guest lecturer in the Life Sciences program at the University of Minnesota’s Carlson Graduate School of Management, a mentor to the annual MNCup startup competition and a co-chair of Medical Alley’s Biotech Shared Interest Group.

Chris is a member of the ISCT’s Market Access & Patient Advocacy subcommittee.

Chris earned his bachelor’s degree in Economics and MBA from the University of California, Berkeley.